We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.36B
AUM Growth
+$353M
(+5.9%)
Cap. Flow
+$69.5M
Cap. Flow
% of AUM
1.09%
Top 10 Holdings %
Top 10 Hldgs %
13.3%
Holding
1,175
New
186
Increased
412
Reduced
363
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$25.8M |
| 2 |
Amazon
AMZN
|
+$22.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$20.3M |
| 4 |
Everest Group
EG
|
+$18.9M |
| 5 |
LKQ Corp
LKQ
|
+$16.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$36M |
| 2 |
UnitedHealth
UNH
|
+$29.5M |
| 3 |
Merck
MRK
|
+$17.8M |
| 4 |
Baxter International
BAX
|
+$17.5M |
| 5 |
Apple
AAPL
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.46% |
| 2 | Financials | 17.64% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Industrials | 12.01% |
| 5 | Healthcare | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Peoples Bancorp
PEBO
$1.45B
| $237K | ﹤0.01% |
6,280
+420
| +7% | +$15.5K |
|
927
Immunic
IMUX
$182M
| $236K | ﹤0.01% |
+86
| New | +$199K |
|
928
SLB Ltd
SLB
$77.8B
| $235K | ﹤0.01% |
3,500
-280
| -7% | -$19.2K |
|
929
Unitil
UTL
$1,000M
| $235K | ﹤0.01% |
+4,600
| New | +$222K |
|
|
PSB
930
DELISTED
PS Business Parks, Inc.
PSB
| $235K | ﹤0.01% |
1,830
| – | – |
|
931
LifeVantage
LFVN
$82.4M
| $231K | ﹤0.01% |
36,246
-9,800
| -21% | -$44.6K |
|
|
MTVA
932
MetaVia Inc
MTVA
$7.64M
| – | – |
0
| – | – |
|
|
ITCI
933
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $228K | ﹤0.01% |
+12,920
| New | +$262K |
|
934
Lisata Therapeutics
LSTA
$15.2M
| $226K | ﹤0.01% |
2,325
-100
| -4% | -$7.05K |
|
|
IVTY
935
DELISTED
Invuity, Inc
IVTY
| $223K | ﹤0.01% |
57,231
+42,331
| +284% | +$147K |
|
|
TCON
936
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $222K | ﹤0.01% |
411
-346
| -46% | -$184K |
|
937
Quaker Houghton
KWR
$2.63B
| $221K | ﹤0.01% |
1,429
| – | – |
|
938
Artisan Partners
APAM
$2.79B
| $220K | ﹤0.01% |
+7,300
| New | +$237K |
|
939
Aviat Networks
AVNW
$262M
| $219K | ﹤0.01% |
26,814
+2,200
| +9% | +$18.9K |
|
|
GNBC
940
DELISTED
Green Bancorp, Inc
GNBC
| $218K | ﹤0.01% |
+10,100
| New | +$232K |
|
941
First Community Bankshares
FCBC
$915M
| $217K | ﹤0.01% |
6,819
| – | – |
|
|
ALDR
942
DELISTED
Alder Biopharmaceuticals
ALDR
| $216K | ﹤0.01% |
+13,700
| New | +$208K |
|
|
SNMX
943
DELISTED
Senomyx, Inc.
SNMX
| $216K | ﹤0.01% |
180,276
| – | – |
|
|
PVLA
944
Palvella Therapeutics
PVLA
$1.98B
| $215K | ﹤0.01% |
+531
| New | +$253K |
|
|
NH
945
DELISTED
NantHealth, Inc
NH
| $215K | ﹤0.01% |
4,329
+3,209
| +287% | +$159K |
|
|
NWY
946
DELISTED
New York & Co Inc
NWY
| $215K | ﹤0.01% |
+42,066
| New | +$172K |
|
947
Lineage Cell Therapeutics
LCTX
$257M
| $214K | ﹤0.01% |
118,687
+38,876
| +49% | +$78.3K |
|
|
WW
948
DELISTED
WW International
WW
| $214K | ﹤0.01% |
+2,120
| New | +$167K |
|
949
Chubb
CB
$140B
| $213K | ﹤0.01% |
+1,680
| New | +$223K |
|
950
Dawson Geophysical
DWSN
$155M
| $213K | ﹤0.01% |
27,021
-3,046
| -10% | -$21.5K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2018 Portfolio in Review
As of Q2 2018, Jacobs Levy Equity Management held 1,175 positions worth $6.36B, up 5.9% from $6.01B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2018 filing shows 186 new, 412 increased, 363 reduced and 161 closed positions. Its largest new stake was LKQ Corp: 486,474 shares worth $15.5M. The largest sale was PepsiCo, an estimated $36M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2018 buy was LKQ Corp: 486,474 shares worth $15.5M.
- Jacobs Levy Equity Management added most to ConocoPhillips in Q2 2018, an estimated $25.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2018 reduction was PepsiCo, cutting an estimated $36M.
- Jacobs Levy Equity Management fully exited General Dynamics in Q2 2018, selling an estimated $11M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.36B portfolio in Q2 2018.
- Jacobs Levy Equity Management opened 186 new positions and closed 161 in Q2 2018.
- Jacobs Levy Equity Management's portfolio value rose 5.9% quarter-over-quarter to $6.36B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.